Equity Capital Markets

Monopar Therapeutics

12/24
|
$40.0 Million
Monopar Therapeutics
Piper Sandler served as bookrunner for Monopar Therapeutics Inc. on its RD and PIPE offering
Sub-Type
Registered Direct
Sub-Sector
Biopharma